Priority-setting for obesity prevention-The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
23
01
2020
accepted:
02
06
2020
entrez:
20
6
2020
pubmed:
20
6
2020
medline:
2
9
2020
Statut:
epublish
Résumé
The aim of the ACE-Obesity Policy study was to assess the economic credentials of a suite of obesity prevention policies across multiple sectors and areas of governance for the Australian setting. The study aimed to place the cost-effectiveness results within a broad decision-making context by providing an assessment of the key considerations for policy implementation. The Assessing Cost-Effectiveness (ACE) approach to priority-setting was used. Systematic literature reviews were undertaken to assess the evidence of intervention effectiveness on body mass index and/or physical activity for selected interventions. A standardised evaluation framework was used to assess the cost-effectiveness of each intervention compared to a 'no intervention' comparator, from a limited societal perspective. A multi-state life table Markov cohort model was used to estimate the long-term health impacts (quantified as health adjusted life years (HALYs)) and health care cost-savings resulting from each intervention. In addition to the technical cost-effectiveness results, qualitative assessments of implementation considerations were undertaken. All 16 interventions evaluated were found to be cost-effective (using a willingness-to-pay threshold of AUD50,000 per HALY gained). Eleven interventions were dominant (health promoting and cost-saving). The incremental cost-effectiveness ratio for the non-dominant interventions ranged from AUD1,728 to 28,703 per HALY gained. Regulatory interventions tended to rank higher on their cost-effectiveness results, driven by lower implementation costs. However, the program-based policy interventions were generally based on higher quality evidence of intervention effectiveness. This comparative analysis of the economic credentials of obesity prevention policies for Australia indicates that there are a broad range of policies that are likely to be cost-effective, although policy options vary in strength of evidence for effectiveness, affordability, feasibility, acceptability to stakeholders, equity impact and sustainability. Implementation of these policies will require sustained co-ordination across jurisdictions and multiple government sectors in order to generate the predicted health benefits for the Australian population.
Identifiants
pubmed: 32559212
doi: 10.1371/journal.pone.0234804
pii: PONE-D-20-02180
pmc: PMC7304600
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0234804Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
JMIR Mhealth Uhealth. 2014 Aug 21;2(3):e37
pubmed: 25147135
Int J Behav Nutr Phys Act. 2008 Sep 10;5:45
pubmed: 18782458
Lancet. 2011 Aug 27;378(9793):826-37
pubmed: 21872751
Pediatrics. 2014 Apr;133(4):e868-74
pubmed: 24590749
Lancet Diabetes Endocrinol. 2013 Oct;1(2):97-105
pubmed: 24349967
Lancet. 2016 Oct 8;388(10053):1659-1724
pubmed: 27733284
PLoS One. 2017 Oct 11;12(10):e0184799
pubmed: 29020093
PLoS Med. 2017 Jun 27;14(6):e1002326
pubmed: 28654688
Nutrients. 2020 Feb 26;12(3):
pubmed: 32110864
BMJ. 2013 Mar 25;346:f1049
pubmed: 23529982
Pharmacoeconomics. 2001;19(11):1103-9
pubmed: 11735677
Lancet. 2010 Nov 20;376(9754):1775-84
pubmed: 21074255
Lancet. 2011 Aug 27;378(9793):804-14
pubmed: 21872749
Pharmacoeconomics. 1998 Apr;13(4):397-409
pubmed: 10178664
Med Sci Sports Exerc. 2011 Aug;43(8):1575-81
pubmed: 21681120
Lancet. 2012 Dec 15;380(9859):2129-43
pubmed: 23245605
Int J Environ Res Public Health. 2014 Apr 14;11(4):4007-25
pubmed: 24736685
Obes Rev. 2009 Jan;10(1):76-86
pubmed: 18761640
BMC Public Health. 2016 Oct 13;16(1):1084
pubmed: 27737707
J Epidemiol Community Health. 2010 Mar;64(3):209-12
pubmed: 19692711
Int J Obes (Lond). 2020 May;44(5):1011-1020
pubmed: 31792336
Int J Obes (Lond). 2019 May;43(5):1102-1112
pubmed: 30926947
Expert Rev Pharmacoecon Outcomes Res. 2008 Dec;8(6):593-617
pubmed: 20528370
Nutrients. 2018 May 15;10(5):
pubmed: 29762517
Scand J Work Environ Health. 2018 Sep 1;44(5):503-511
pubmed: 30078034
Nutrients. 2017 Sep 06;9(9):
pubmed: 28878175
Int J Obes (Lond). 2006 Oct;30(10):1463-75
pubmed: 17003807
BMC Public Health. 2009 Nov 18;9:419
pubmed: 19922625
Obes Rev. 2005 Feb;6(1):23-33
pubmed: 15655036
Nutrients. 2018 May 14;10(5):
pubmed: 29757979
BMC Public Health. 2017 May 4;17(1):359
pubmed: 28468618
Aust N Z J Public Health. 2010 Jun;34(3):240-7
pubmed: 20618263
Curr Obes Rep. 2020 Jun;9(2):150-158
pubmed: 32266649
Health Promot J Austr. 2018 Jul;29 Suppl 1:7-9
pubmed: 29667784
JAMA. 2013 Aug 14;310(6):591-608
pubmed: 23842577
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897